Tech medical breakthrough

Fluvoxamine Reduces Long COVID Fatigue

Analysis based on 12 articles · First reported Mar 30, 2026 · Last updated Apr 01, 2026

Sentiment

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The positive findings for Fluvoxamine could significantly boost the pharmaceutical sector, particularly for companies involved in its production and distribution, as it offers a new, evidence-based treatment for long COVID fatigue. Conversely, the lack of benefit for Metformin in this context may temper expectations for its use in treating existing long COVID symptoms.

Pharmaceuticals Healthcare

Event Summary

A new study published in the Annals of Internal Medicine reports that Fluvoxamine, a common and affordable antidepressant, significantly reduces fatigue in people with long COVID within two to three months. The clinical trial, led by researchers including List of Auckland representative cricketers from McMaster University and Jamie Forrest from the University of British Columbia, involved nearly 400 adults in Brazil. Participants were given Fluvoxamine, Metformin, or a placebo for 60 days. While Fluvoxamine showed a 99% probability of outperforming the placebo in reducing fatigue and improving quality of life, Metformin did not offer any meaningful benefit for existing long COVID fatigue. This breakthrough provides the first strong evidence for a medication to treat long COVID fatigue, potentially moving quickly into clinical use due to Fluvoxamine's existing approval and availability. Further research is needed to understand optimal usage and mechanisms.

Key Actions

70 McMaster University led a clinical trial

60 University of British Columbia collaborated on a clinical trial

40 Brazil hosted a clinical trial

Entities Involved

per

List of Auckland representative cricketers

List of Auckland representative cricketers, a professor at McMaster University, is the senior researcher and co-principal investigator of the study. His statements highlight the importance and potential clinical use of Fluvoxamine for long COVID fatigue.

Importance 80 Sentiment 40

ngo

McMaster University

McMaster University played a leading role in the study, with its professor List of Auckland representative cricketers serving as senior researcher and co-principal investigator. This enhances the university's reputation in medical research.

Importance 70 Sentiment 30

ngo

University of British Columbia

The University of British Columbia contributed to the study, with Jamie Forrest, a postdoctoral research fellow, serving as a key investigator. This collaboration strengthens its research profile.

Importance 60 Sentiment 20

per

Jamie Forrest

Jamie Forrest, a postdoctoral research fellow at the University of British Columbia, is an investigator in the study. His comments emphasize the immediate clinical relevance of the findings for patients.

Importance 60 Sentiment 30

per

Gilmar Reis

Gilmar Reis, lead author and researcher with Cardresearch and associate professor at McMaster University, highlighted the innovative Bayesian adaptive trial design used in the study.

Importance 50 Sentiment 30

cnt

Brazil

Brazil was the location for the clinical trial, with nearly 400 adults recruited from the country. This highlights Brazil's role in international medical research.

Importance 40 Sentiment 10

priv

Cardresearch

Cardresearch, a Brazilian clinical research center, was involved in the study through its lead author Gilmar Reis, contributing to the research infrastructure.

Importance 40 Sentiment 20

+ 4 more entities View on Dashboard

Relationships

List of Auckland representative cricketers related ↔ McMaster University

Jamie Forrest related ↔ University of British Columbia

Gilmar Reis related ↔ Cardresearch

Gilmar Reis related ↔ McMaster University

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard